ATE278024T1 - Methode zur herstellung von rekombinanten zellen - Google Patents

Methode zur herstellung von rekombinanten zellen

Info

Publication number
ATE278024T1
ATE278024T1 AT99961864T AT99961864T ATE278024T1 AT E278024 T1 ATE278024 T1 AT E278024T1 AT 99961864 T AT99961864 T AT 99961864T AT 99961864 T AT99961864 T AT 99961864T AT E278024 T1 ATE278024 T1 AT E278024T1
Authority
AT
Austria
Prior art keywords
recombinant
cell lines
recombinant cells
producing recombinant
amino acid
Prior art date
Application number
AT99961864T
Other languages
English (en)
Inventor
Jorge L Acevedo
Peter R Rhode
Original Assignee
Sunol Molecular Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunol Molecular Corp filed Critical Sunol Molecular Corp
Application granted granted Critical
Publication of ATE278024T1 publication Critical patent/ATE278024T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99961864T 1998-12-03 1999-11-30 Methode zur herstellung von rekombinanten zellen ATE278024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/204,979 US6156514A (en) 1998-12-03 1998-12-03 Methods for making recombinant cells
PCT/US1999/028255 WO2000032821A1 (en) 1998-12-03 1999-11-30 Methods for making recombinant cells

Publications (1)

Publication Number Publication Date
ATE278024T1 true ATE278024T1 (de) 2004-10-15

Family

ID=22760275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99961864T ATE278024T1 (de) 1998-12-03 1999-11-30 Methode zur herstellung von rekombinanten zellen

Country Status (12)

Country Link
US (2) US6156514A (de)
EP (1) EP1137808B1 (de)
JP (1) JP2002531103A (de)
CN (1) CN1202261C (de)
AT (1) ATE278024T1 (de)
AU (1) AU770119B2 (de)
CA (1) CA2353575A1 (de)
DE (1) DE69920747T2 (de)
DK (1) DK1137808T3 (de)
ES (1) ES2230908T3 (de)
TW (1) TWI221483B (de)
WO (1) WO2000032821A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
AU2001271614B2 (en) * 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
WO2003064659A1 (en) * 2002-01-11 2003-08-07 Genetica, Inc. Methods and compositions for optimizing recombinant expression
CA2486464A1 (en) 2002-05-21 2003-11-27 Resistentia Pharmaceuticals Ab Chimeric ige polypeptides and host cells
PL377653A1 (pl) * 2003-01-09 2006-02-06 Genentech, Inc. Oczyszczanie polipeptydów
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
WO2007085266A1 (en) * 2006-01-30 2007-08-02 Dako Denmark A/S High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
EP2361930A3 (de) 2007-03-26 2011-10-26 Dako Denmark A/S Multimere von peptide-mhc komplexen und deren verwendung in borrelia infektionskrankheiten
EP2167537A2 (de) 2007-07-03 2010-03-31 Dako Denmark A/S Zusammengestellte verfahren für die analyse und sortierung von proben
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010009735A2 (en) * 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
EP3319631A4 (de) 2015-07-08 2019-01-09 American Gene Technologies International Inc. Hiv-vorimmunisierung und immuntherapie
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
CA3011529A1 (en) 2016-01-15 2017-07-20 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta t-cells
US10888613B2 (en) 2016-02-08 2021-01-12 American Gene Technologies International Inc. Method of producing cells resistant to HIV infection
ES2911448T3 (es) 2016-03-09 2022-05-19 American Gene Tech Int Inc Vectores combinados y métodos para el tratamiento del cáncer
EP3468617A4 (de) 2016-06-08 2020-01-22 American Gene Technologies International Inc. System zur nichtintegralen viralen ausgabe und verfahren im zusammenhang damit
IL300730A (en) 2016-07-08 2023-04-01 American Gene Tech Int Inc Pre-HIV vaccine and immunotherapy
JP7176756B2 (ja) 2016-07-21 2022-11-22 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド パーキンソン病を処置するためのウイルスベクター
US11820999B2 (en) 2017-04-03 2023-11-21 American Gene Technologies International Inc. Compositions and methods for treating phenylketonuria
US12258373B2 (en) 2018-12-17 2025-03-25 Immudex Aps Panel comprising Borrelia MHC multimers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167442D1 (en) * 1980-07-07 1985-01-10 Nat Res Dev Improvements in or relating to cell lines
US4766067A (en) * 1985-05-31 1988-08-23 President And Fellows Of Harvard College Gene amplification
IL80511A0 (en) * 1985-11-05 1987-02-27 Genetics Inst Multiply amplifiable vectors for high level expression of exogenous dna
RU2091487C1 (ru) * 1987-02-27 1997-09-27 Гист-Брокейдс Н.В. Способ получения штамма bacillus, содержащего две копии последовательности днк, кодирующей фермент с гидролазной активностью
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
WO1989010959A1 (en) * 1988-05-06 1989-11-16 Codon Supertransformants for high expression rates in eukaryotic cells
AU4741090A (en) * 1988-12-08 1990-06-26 Damon Biotech Inc. Expression induction method employing mutant dhfr gene
DK0587791T3 (da) * 1991-05-31 2004-07-26 Genentech Inc Forstærkelse af ekspression ved hjælp af gentargeting i endogene retroviruslignende sekvenser
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
CA2169292C (en) * 1993-08-12 2010-11-23 E. Edward Baetge Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5733782A (en) * 1993-10-25 1998-03-31 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US5585237A (en) * 1993-10-25 1996-12-17 Creative Biomolecules, Inc. Methods and compositions for high protein production from recombinant DNA
WO1995017513A1 (en) * 1993-12-23 1995-06-29 Novo Nordisk A/S Retransformation of filamentous fungi
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods

Also Published As

Publication number Publication date
CA2353575A1 (en) 2000-06-08
ES2230908T3 (es) 2005-05-01
US6156514A (en) 2000-12-05
AU770119B2 (en) 2004-02-12
AU1835600A (en) 2000-06-19
US6306605B1 (en) 2001-10-23
TWI221483B (en) 2004-10-01
EP1137808B1 (de) 2004-09-29
DE69920747D1 (de) 2004-11-04
DK1137808T3 (da) 2005-01-31
JP2002531103A (ja) 2002-09-24
DE69920747T2 (de) 2005-10-06
EP1137808A1 (de) 2001-10-04
CN1202261C (zh) 2005-05-18
EP1137808A4 (de) 2002-10-02
WO2000032821A1 (en) 2000-06-08
CN1328605A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
DE69920747D1 (de) Methode zur herstellung von rekombinanten zellen
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
ATE213271T1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte- fermentation
BRPI0411475A (pt) adições de código genético de aminoácido reativo não natural
DE60232773D1 (de) Verfahren zur Herstellung von Membran-Elektrode-Anordnungen für Brennstoffzellen
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
DE69417011D1 (de) Verfahren zur herstellung von kathoden komponenten und zu ihrer verwendung in elektrochemischen zellen
DE60228460D1 (de) Verfahren zur Herstellung und Reinigung von Erythropoietin
CY1105772T1 (el) Συνθεσεις και μεθοδοι για βελτιωμενη κυτταρικη καλλιεργεια
DE60331226D1 (de) Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
ATE111956T1 (de) Co-expression in eukaryontischen zellen.
DE69939548D1 (de) Verfahren zur herstellung von faktor vii
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
DE69604550D1 (de) Verfahren zur Herstellung von Lithiumionzelle mit deaktivierter Kohlenstoffanode
ATE362544T1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
WO2004053137A3 (en) Method for protein production
BRPI0512798A (pt) molécula de ácido nucleico recombinante, célula, método para produzir uma proteìna de interesse, uso de uma seqüência de ácido nucleico tendo atividade anti-repressora, métodos para gerar uma célula hospedeira expressando dois polipeptìdios de interesse, e para expressar dois polipeptìdios de interesse
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
WO2002008417A1 (fr) Procede de production d'une proteine de recombinaison
ATE273391T1 (de) Neurotrophischer faktor nnt-1
DE69933699D1 (de) Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin
DE69939876D1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137808

Country of ref document: EP